Transcription of Tuesday, 15 May 2018 Registration and Welcome …
{{id}} {{{paragraph}}}
Example: biology
Tuesday, 15 May 2018 Registration and Welcome …
Tuesday, 15 May 2018 Break08:00 - 09:30 FoyerRegistration and Welcome CoffeePlenary Session09:30 - 10:00 Congress HallWelcome Address 09:30 - 10:00 CIMT President Christoph HuberPlenary Session10:00 - 11:30 Congress HallCellular TherapyChair: Harpreet Singh (Immatics Biotechnologies, Houston, United States) 10:00 - 10:30 New modes of T-cell cancer recognition by dissection of immunotherapysuccesses Speaker: Andrew Sewell (Cardiff University, Cardiff, United Kingdom) 10:30 - 11:00 ADAP ting to solid tumors, advances and challenges for TCR T-cell therapy Speaker: Gwen Binder-Scholl (Adaptimmune, Philadelphia, United States) 11:00 - 11:30 TIL therapy in melanoma: history of clinical development, current statusand plans for the future Speaker: Rodabe Amaria (University of Texas MD Anderson Cancer Center,Houston, United States)Break11:30 - 13:30 FoyerLunchCorporate Supported Symposium12:00 - 13:00 Congress Hall"Immunooncology 2018 and beyond" supported by Bristol-Myers SquibbChair: Dirk J ger (National Center for Tumor Diseases, Heidelberg, Germany)Page 1 / 24 CIMT 2018 Scientific Programme 12:00
HepaVac-101 first-in-man therapeutic cancer vaccine phase I/II clinical trial for hepatocellular carcinoma patients Speaker: Luigi Buonaguro (Istituto Nazionale Tumori Pascale, Napoli, Italy)
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: